PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Part of paid clinical trials in Galveston, Texas.

Sponsor
University of Utah
Study ID
NCT06945484
Status
Recruiting

Conditions

  • NSCLC Stage II
  • NSCLC, Stage III

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Precision Exercise Regimen for Cancer Care (PERCC) — OTHER
    PERCC has exercise modes including basic transfer and calisthenics mobility, aerobic, and resistance exercises, and will be performed in various postures (supine, sitting, standing, and walking) with variable challenges (level walking, bending, inclines, steps, and squatting). Each participant will complete one supervised, home-based exercise training session per week, delivered through telehealth, that will focus on the resistance exercise prescription. Other unsupervised exercise training sessions will focus on the aerobic exercise prescription and will be completed individually

Study Details

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Key Dates

Start date
Nov 21, 2025
Status verified
Jul 2025
Primary completion
Jan 31, 2027
Completion
Dec 31, 2030

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Precision Exercise Regimen for Cancer Care (PERCC)
    Participants will engage in PERCC starting at least two weeks prior to receiving their first neoadjuvant treatment for lung cancer and continuing until two months after receiving surgical treatment.

Primary Outcome Measure

Feasibility - Recruitment and Retention [ Time Frame: up to two months post-surgery ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of Texas Medical Branch at GalvestonGalvestonTexas77555
Rebecca Geck, MSN/MPH
409-266-0496
Huntsman Cancer InstituteSalt Lake CityUtah84112
Cornelia Ulrich, MS, PhD

Find similar trials in Galveston, TX

Related Studies